Cosmo Feilding-Mellen, CEO, Beckley Psytech, charts the role of psychedelics in mitigating Treatment Resistant Depression
This post has been moved. Please continue reading here.
https://www.openaccessgovernment.org/article/psychedelics-mitigate-treatment-resistant-depression/163713/
Researchers find that ‘moderate to high’ workplace stress levels have risen by 13% since 2022. What can employers do to help their employees during this time?
AI's impact on mental health cannot be ignored; research reveals frequent interaction with artificial intelligence systems increases the likelihood of loneliness, insomnia and increased after-work drinking.
Mental health used to be rarely spoken about, but the current mental health crisis has been brewing for years, and the COVID-19 pandemic finally put it in the spotlight.
The government has developed a £3.7 million peer mentor and employment programme for people with substance dependence to seek help from those who have beat addiction.
In a surprising turn of events, Prince Harry's public endorsement of the transformative power of psychedelic therapy has triggered a psychedelic resurgence in the UK.
With mental health issues on the rise, Ryan Exley from the Institution of Occupational Safety and Health explains why organisations must understand risk factors for poor mental health at work and implement measures to protect the wellbeing of their staff.
